Synergy Pharmaceuticals (FRA:S90) Other Long Term Assets : €0.27 Mil (As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Other Long Term Assets?

Synergy Pharmaceuticals's other long-term assets for the quarter that ended in Sep. 2018 was €0.27 Mil.

Synergy Pharmaceuticals's quarterly other long-term assets increased from Mar. 2018 (€0.25 Mil) to Jun. 2018 (€0.27 Mil) and increased from Jun. 2018 (€0.27 Mil) to Sep. 2018 (€0.27 Mil).

Synergy Pharmaceuticals's annual other long-term assets increased from Dec. 2015 (€0.32 Mil) to Dec. 2016 (€0.33 Mil) but then declined from Dec. 2016 (€0.33 Mil) to Dec. 2017 (€0.26 Mil).

Synergy Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Synergy Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Other Long Term Assets Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Other Long Term Assets

Get a 7-Day Free Trial

0.07

0.13

0.32

0.33

0.26

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Other Long Term Assets	Get a 7-Day Free Trial															0.27	0.26	0.25	0.27	0.27

Synergy Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines